Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PTGDR2 | Q9Y5Y4 | 7/20 | 0.35 |
| ▸ | PPARG | P37231 | 3/20 | 0.34 |
| ▸ | PPARD | Q03181 | 3/20 | 0.34 |
| ▸ | PPARA | Q07869 | 3/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | SLC6A9 | P48067 | 4/20 | 0.33 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.32 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27044941 | 0.93 | LMNA (0.33) | MEN1LMNAKMT2ABCAT2BCAT1 | |
| SCHEMBL27047407 | 0.90 | PKM (0.35) | LMNAPTGDR2PPARGPPARDPPARA | |
| SCHEMBL29452544 | 0.88 | PPOX (0.33) | MEN1LMNAKMT2APPARGPPARD | |
| SCHEMBL27044932 | 0.88 | PPOX (0.33) | MEN1LMNAKMT2APPARGPPARD | |
| SCHEMBL29709398 | 0.88 | PKM (0.34) | PPARGPPARDPPARAPKM | |
| SCHEMBL27047411 | 0.88 | BCAT2 (0.39) | PTGDR2PPARGPPARDPPARABCAT2 | |
| SCHEMBL27047417 | 0.87 | ALDH1A1 (0.36) | MEN1LMNAKMT2APTGDR2 | |
| SCHEMBL29452833 | 0.86 | DHODH (0.35) | LMNAKMT2APTGDR2PPARGBCAT2 | |
| SCHEMBL25295816 | 0.86 | DHODH (0.35) | LMNAKMT2APTGDR2PPARGBCAT2 | |
| SCHEMBL3245244 | 0.85 | BCAT1 (0.39) | MEN1LMNAKMT2APTGDR2RORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138958-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AG (DE) | 2026-05-21 | — | — | US | disclosed |
| EP-4602036-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | Bayer Aktiengesellschaft (DE) | 2025-08-20 | — | — | EP | disclosed |
| CN-120035584-A | Substituted N-phenyluracils and salts thereof and their use as herbicidal agents | 拜耳公司 | 2025-05-23 | — | — | CN | disclosed |
| EP-4200282-B1 | SUBSTITUTED N-PHENYLURACILS AS WELL AS THEIR SALTS AND THEIR USE AS HERBICIDES. | BAYER AG (DE) | 2024-09-11 | — | — | EP | disclosed |
| WO-2024078906-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-04-18 | — | — | WO | disclosed |
| US-20240025862-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-01-25 | — | — | US | disclosed |
| US-20240025862-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-01-25 | — | — | US | disclosed |
| EP-4200282-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | Bayer Aktiengesellschaft (DE) | 2023-06-28 | — | — | EP | disclosed |
| WO-2022043205-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2022-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138958-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | CBR1, CBR3, HDHD5 | MEN1 4233/4885LMNA 2296/4885KMT2A 2946/4885 |
| US-20240025862-A1 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | PFAS, DDT, NOTUM | MEN1 4557/4885LMNA 3856/4885KMT2A 1736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.